Skip to main content

Agenus Inc. (AGEN) Stock Forecast

Data as of Aug 8, 2026

Healthcare · Current price $7.03 (-6.21%)

Consensus Target
$7.33
Upside
-1.4%
Analysts
2
Rating
Buy(2.00)

Price Target Range

Low $7.00Consensus $7.33High $8.00
▲ Current $7.03

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

AGEN vs Sector & Market

MetricAGENHealthcare AvgLarge Cap Avg
Analyst Rating2.002.252.42
Analyst Count2818
Target Upside-1.4%+16316.2%+17.2%
P/E Ratio1194.752.4836.06

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$32M$35M$37M1
2026-12-31$32M$35M$37M1
2027-03-31$27M$29M$31M1
2027-06-30$27M$29M$31M1
2027-09-30$27M$29M$31M1
2027-12-31$27M$29M$31M1
2028-12-31$106M$108M$110M2
2029-12-31$124M$126M$128M1
2030-12-31$170M$173M$175M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$0.21$0.23$0.251
2026-12-31$0.17$0.19$0.211
2027-03-31$-0.97$-0.89$-0.821
2027-06-30$-0.98$-0.91$-0.831
2027-09-30$-0.99$-0.91$-0.841
2027-12-31$-0.98$-0.90$-0.831
2028-12-31$-2.12$-1.54$-0.962
2029-12-31$-1.04$-1.02$-1.001
2030-12-31$-0.11$-0.11$-0.111

Frequently Asked Questions

What is the analyst consensus for AGEN?

The consensus among 2 analysts covering Agenus Inc. (AGEN) is Buy with an average price target of $7.33.

What is the highest price target for AGEN?

The highest analyst price target for AGEN is $8.00.

What is the lowest price target for AGEN?

The lowest analyst price target for AGEN is $7.00.

How many analysts cover AGEN?

2 analysts have issued ratings for Agenus Inc. in the past 12 months.

Is AGEN a buy or sell right now?

Based on 2 analyst ratings, AGEN has a consensus rating of Buy (2.00/5) with a -1.4% upside to the consensus target of $7.33.

What are the earnings estimates for AGEN?

Analysts estimate AGEN will report EPS of $0.23 for the period ending 2026-09-30, with revenue estimated at $35M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.